0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Lessons learnt from the International Peer Review Week 2022 with the theme – ”Research Integrity: Creating and supporting trust in research”

      editorial
      Indian Journal of Ophthalmology
      Wolters Kluwer - Medknow

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          In scholarly publishing, peer review is the single most important aspect that helps maintain the quality and integrity of published papers. In the conventional prepublication peer review process (more on alternate models later), a journal editor often asks reviewers to give their opinion about the rationale for the study, methodology used, statistical analysis done, robustness and accuracy of the results, and whether conclusions are data driven. Though reviewing standards have been benchmarked based on the tireless work and recommendations of organizations such as the Committee of Publication Ethics (COPE), International Committee of Medical Journal Editors, and the Equator Network (Enhancing the QUAlity and Transparency Of health Research), let’s remember that the peer review process is entirely subjective and prone to errors. Some large-scale papers have slipped through the peer review sieve from some of the top journals, only to be retracted later.[1] So how do we achieve research integrity and create trust in research from a peer review angle? This was the central theme of the peer review week 2022, i.e., “Research Integrity: Creating and supporting trust in research” that happened from September 19 to 23, 2022. So what is International Peer Review week (PRW)? This is a virtual global event revolving around the essential role that peer review plays in maintaining scientific quality and is organized every September by a steering committee.[2] The purpose of the PRW every year is to get all stakeholders including journal publishers, editors, reviewers, authors, funders, and all others on one forum and discuss some of the important aspects plaguing peer review. The theme last year was “Identity in peer review” and the theme this year, as mentioned above, was how to improve research integrity and create trust in research. I managed to attend a lot of online events conducted by several leading organizations such as the COPE, Accelerating Science and Publication in biology (ASAPbio), Editage Insights, Research Square Company, Scholastica, and many others. In this guest editorial, I discuss some of my learnings in a point-wise fashion and hope that this will enlighten readers on some of the emerging malpractices related to publishing and some solutions to counter this from the editorial and peer review point of view. Paper Mills: These are groups (or companies) that can produce totally fraudulent papers (without any data) for a fee and make them look totally authentic OR offer authorship for a fee OR can even rig the entire review process (e.g., insert guest editors, offer a fee to reviewers) in multiple ways. These are an increasing threat to research integrity and were the highlight of a lot of discussions during PRW. We need systems to weed these out including cross collaboration between publishers, methods to blacklist them, etc., The COPE has come up with an excellent document on this in collaboration with STM, and I highly recommend reading this resource.[3] The “STM Research Integrity hub” is also an excellent resource should you want to learn more about this.[4] Plagiarism: i.e., taking undue credit for others’ work without proper attribution remains a big concern in academic publishing. Most top journals, including the IJO, use the iThenticate software to detect plagiarism. The iThenticate-V2 (a new version) is coming soon and has several additional features/filters, such as opting for specific sections of the paper (e.g., opt out of Methods), the ability to detect paraphrasing (in the process), faster and more user-friendly, etc., However, the biggest revelation for me from discussions during the PRW was that a high “Similarity index” does not always mean plagiarism and a very low index is also unusual. Journal editors need to look at individual reports carefully. Therefore, having a threshold similarity index to label as plagiarism is not the best idea. Self-plagiarism needs to be contained by authors since this is also picked up by iThenticate. Lastly, a journal’s plagiarism policy should be clear on the author’s instructions page, and the point at which plagiarism is checked should be clearly mentioned. Images are also plagiarized and are not yet recognized by software like iThenticate. Newer AI-driven software like “Image Twin” helps recognize manipulated images outside the preview of current plagiarism software. Contract cheating: Outsourcing your work to an external agency without doing any work at all to satisfy authorship criteria is also considered academic misconduct and is labeled as “contract cheating.” It is advised that you do the bulk of the work and then use external assistance if needed (e.g., advanced stats or language edits). This falls under the domain of Paper mills somewhat (see Point 1 above) Micropublishing: This is a new concept and publishes brief, novel findings, negative and/or reproduced results, and results that may lack a broader scientific narrative (quoted directly from the website). This can be explored more directly at the microPublication website.[5] This provides rapid peer review and publication and is indexed in PubMed and all other major indexing services. Preprints: Several preprint servers are now operational, and this is evolving rapidly, especially during and after the pandemic, with many repositories at present. An entire list is available on the ASAPbio website,[6] which is doing a phenomenal job in setting up standards in preprinting and bringing transparency to this process. Preprint plagiarism is also an emerging major concern that needs to be tackled by collaboration between various servers. A lot of discussions during the PRW hinted toward making preprinting mainstream. Additionally, since the tide on mandatory data sharing is changing, with authors mandated or encouraged by journals to submit their original datasheets for peer review, preprint servers can archive these datasets securely along with the manuscript. Also, a lot of journals, as well as preprint servers, are adopting the FAIR Data Principles (FAIR stands for making data Findable, Accessible, Interoperable, and Reusable), and preprint servers could promote this to a large extent. Transparent (Open) peer review: Open peer review means that the identity of the reviewers is made available (with the concerned reviewer’s consent) along with his/her comments, timeliness, and final recommendations, once the paper is published. This will certainly improve reviewer performance, and a lot of journals such as the BMJ group have adopted this strategy. Open peer review is another direction toward open science that includes open access publishing models, preprinting, getting a DOI before journal acceptance, open review, final editorial decision, then acceptance, publication into the journal website, and finally indexing in PubMed. The “International Open Access Week” is another global virtual event like the PRW and is conducted in the last week of October every year. Discourage reviewers from asking authors to cite the reviewer’s own work. This is an inherent and rampant problem that needs to be dealt with and was discussed during the PRW. Reviewers must be asked to declare their conflict of interest without exception before they review the paper. All journals need to adopt this and should be part of the reviewer guidelines and journal standard operating procedures. These are some of the things that are undermining peer review integrity at the moment and were discussed at length at various forums during the recently concluded PRW. I hope that some of the new terminologies I have put forward will be beneficial to editors, reviewers, and prospective authors alike and that you will be inspired to not only conduct your own research with integrity but also review papers with the utmost integrity, with the sole purpose of upliftment of science. I also sincerely hope that many of you will follow the international PRW in the coming years and keep learning new things about the peer review process, and perhaps even contribute to its betterment. About the author Dr. Sabyasachi Sengupta Dr. Sabyasachi Sengupta is a practicing vitreoretinal surgeon at Future Vision eye care, Mumbai. He is the founder and director of Sengupta’s research academy, where he offers courses for training budding researchers on techniques of research methodology. He completed his DNB ophthalmology from Aravind Eye Hospital, Pondicherry and received the Dr G. Venkataswamy gold medal for the DNB exam held in December 2009. He finished his surgical retina training from Sankara Nethralaya and went on to do a postdoc clinical research fellowship at Wilmer Eye Institute, Johns Hopkins. He has received the MacCartney prize from the Royal College of Ophthalmologists for ranking first globally in the ocular pathology section of the FRCOphth fellowship exam, and has the distinction of being the first ever non-British national to receive this award. He has received more than 15 distinguished awards so far. Dr Sengupta has published 100 + papers in peer-reviewed journals and is a regular invited faculty on research methodology both in India and abroad.

          Related collections

          Most cited references1

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          An editorial perspective on the infamous COVID-19 studies retracted by Lancet and NEJM

          Over the past 1 month, a story of extreme deceit, data fabrication and publication fraud has emerged from some of the very top journals in medicine. I am certain that by now, most of you have heard about the retracted papers on hydroxychloroquine (HCQ) by Lancet,[1 2] and on cardiovascular disease, drug therapy and mortality related to COVID-19 by the New England Journal of Medicine.[3 4] Incidentally, both these papers were written by the same authors and data were derived from the same international registry, the validity of which could not be confirmed by independent review teams. The paper claiming that HCQ lead to serious cardiovascular side effects caused ripple effects throughout the scientific community,[1] and prompted the World Health Organization (WHO) to temporarily halt recruitment of the international Solidarity trial, evaluating the role of HCQ in COVID-19.[5] With the retractions, one might believe that justice has been done. However, credit must still be given to the journals, their editors who expressed concern,[6] and above all, the lead author who has swallowed his ego and done the right thing by publicly apologizing and asking for a retraction himself.[2] It takes a lot of courage to admit a mistake, and in my opinion, these retractions should restore faith in the peer review process once again. The fact that these papers were caught red-handed almost instantaneously means that the retractions were timely and not much scientific damage was done. However, I wonder whether psychological damage is done in the minds of physicians who believed in these journals as gospels. In the wake of these events, we seem to be suddenly questioning the very foundations of evidence-based medicine and trying to find reasons to discredit decades of honestly done scientific research that has influenced our practice patterns. An even more dangerous precedent is also emerging amongst many elite and senior physicians who once again recommend falling back on clinical acumen and personal experience and not on data-driven recommendations. This is an impression that is difficult to reverse, can spread very quickly and impact impressionable young minds, which represent the future of healthcare. The real question is, can you trust yourself and your acumen all the time, and on what basis? It's hard to see trends and see what is working and what is not until you analyze your results critically and your findings are accepted by your peers. I think there is still a lot of merit in data-driven recommendations rather than anecdotes and personal experience. I appeal to you to still believe in these fundamentals. The journey of a research paper from concept to fruition goes through many sieves and faces many checks and balances before it is in print. In these retracted papers, a lot of these balances seem to have been missed. The author's misconduct of using potentially fabricated data (or at least some of it) notwithstanding, the journal review process missed the fact that the source of the data might be fraudulent. But if you review the published papers carefully, you will notice that everything looks perfectly in place to the naked eye, even to expertly trained eyes of the reviewers who might have reviewed it. The study design looked impeccable, the statistics were good, and the results were expertly presented and discussed beautifully. But the reviewers failed to see the fact that it is next to impossible to have an international registry of the sort mentioned in the paper due to data protection laws, different data formats, de-identification issues and many more hurdles. One must also remember that when the rewards of publishing in the apex journals are huge, the risks taken to commit and then hide misconduct are also huge. The owner of the registry, who was highly likely to have financial interests in publishing such a paper and claim credit and publicity for his database, was the second author in both the Lancet and NEJM papers. Ironically, he has authored papers on ethics and fraud in research himself.[7] It is easy to point these out in retrospect but it is a major lapse on the part of the reviewers to have missed this. But lets face it, most journal editors and reviewers do not ask for the datasheet in 99.99% of cases. However, after this fiasco, this might change. We will now see more and more journals asking authors to submit their datasheets along with their manuscript submissions. For journals who don't, it may be prudent for the authors to themselves upload their datasheets on online repositories such as research gate or research square and mention this in their manuscript cover letters. Retractions are extremely serious events for any journal and taken very seriously by the editorial board, the parent scientific organization the journal represents, the publisher, and the indexing authorities. At the beginning of the tenure of the current editorial board of the Indian journal of ophthalmology, we had published an editorial on publication ethics covering all these topics including data fabrication, publication fraud, plagiarism and retractions.[8] Most guidelines on retractions are given by the committee of publication ethics (COPE), which state that “editors should consider retracting a publication if they have clear evidence that the findings are unreliable, either as a result of major error (e.g., miscalculation or experimental error), or as a result of fabrication (e.g., of data) or falsification (e.g., image manipulation), it constitutes plagiarism, the findings have previously been published elsewhere without proper attribution to previous sources or disclosure to the editor, permission to republish, or justification (i.e., cases of redundant publication), it contains material or data without authorization for use, copyright has been infringed or there is some other serious legal issue (e.g., libel, privacy), it reports unethical research, it has been published solely based on a compromised or manipulated peer review process, the author(s) failed to disclose a major competing interest (a.k.a. conflict of interest) that, in the view of the editor, would have unduly affected interpretations of the work or recommendations by editors and peer reviewers.[9] The notice of retraction should be published with the link to the retracted paper and with clear reasons for retraction. The retracting authority should also be declared. In the current case, the authors themselves asked for a retraction and furnished an apology which was published online.[2 3] We follow the same guidelines given by the COPE at IJO and the editorial board is ever vigilant so that papers with major deficiencies do not slip through the sieves of our review process. In conclusion, the past month has possibly witnessed the biggest attempted heist in the history of scientific publications, akin to the Cambridge Analytica fiasco during the American presidential elections in 2016. This attempt at maligning the entire fundamentals of clinical research is worthy of protests and black armbands. But lets not vilify honest attempts at clinical research and data-driven recommendations for patient care, which ultimately supplement your acumen and help you get better results for your patients. Research needs to be meaningful and have clinical applications impacting our practices. Publishing for other motivations might lead you to cut corners and dodge scientific inquiry methods, which is never desirable. When the rewards are large, chances of misconduct are high; hence the editors, reviewers and the readership should have a high index of suspicion to weed these out. The application of clinical research to practice requires you to critically analyze papers, and question its validity before adopting the treatment guidelines. Before parting, I would like to emphasize that the onus of treating patients is ultimately on us. Let us all tighten up and learn some basic techniques of research so that we can make the best decision for patients and perform the best possible research going forwards. About the author Dr. Sabyasachi Sengupta Dr. Sabyasachi Sengupta is a practicing vitreoretinal surgeon at Future Vision eye care, Mumbai. He is the founder and director of Sengupta's research academy where he offers courses for training budding researchers on techniques of research methodology. He completed his DNB ophthalmology from Aravind Eye Hospital, Pondicherry and received the Dr G.Venkataswamy gold medal for DNB exam held in December, 2009. He finished his surgical retina training from Sankara Nethralaya and went on to do a post-doc clinical research fellowship at Wilmer Eye Institute, Johns Hopkins. He has received the MacCartney prize from the Royal college of Ophthalmologists for ranking first globally in the ocular pathology section of the FRCOphth fellowship exam, and has the distinction of being the first ever non-British national to receive this award. He has received more than 15 distinguished awards so far. Dr Sengupta has published 90 papers in peer reviewed journals and is a regular invited faculty on research methodology both in India and abroad.
            Bookmark

            Author and article information

            Journal
            Indian J Ophthalmol
            Indian J Ophthalmol
            IJO
            Indian J Ophthalmol
            Indian Journal of Ophthalmology
            Wolters Kluwer - Medknow (India )
            0301-4738
            1998-3689
            December 2022
            December 2022
            : 70
            : 12
            : 4099-4100
            Affiliations
            [1]Future Vision Eye Care and Research Centre, Mumbai, Maharashtra, India. E-mail: drsunny1980@ 123456gmail.com
            Article
            IJO-70-4099
            10.4103/IJO.IJO_2920_22
            9940577
            36453293
            e352444a-ca52-42ce-851e-e1806393e6e6
            Copyright: © 2022 Indian Journal of Ophthalmology

            This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

            History
            Categories
            Guest Editorial

            Ophthalmology & Optometry
            Ophthalmology & Optometry

            Comments

            Comment on this article